Drug resistance reversal and survivin action mechanism of Fe3O4 magnetic nanoparticles on hepatocellular carcinoma cells

Author:

Chen Jiacheng1,Chen Xiaojing2,Chen Liang1,Luo Xiangxiang1,Zhuang Chunyu2,Wu Jincai1

Affiliation:

1. Department of Biliary and Pancreatic Surgery, Hainan Provincial People’s Hospital, Haikou, Hainan, 570100, China

2. Nursing Department, Haikou Maternal and Child Health Hospital, Haikou, Hainan, 571100, China

Abstract

We herein studied mechanism of drug resistance reversal and survivin action of Fe3O4 magnetic nanoparticles on hepatocellular carcinoma cells. Fe3O4 was prepared and co-cultured with HepG2/Adriamycin (ADM). Results showed that, A value of liver cancer group was lower than that multidrug resistance group at different time points (P <0.05). The A value of multidrug resistance at different time points was higher than nano group (P <0.05). Compared with liver cancer, multidrug resistance group showed different degrees of resistance to ADM, cisplatin (DDP), 5-FU and Vincristine (VCR), with drug resistance indexes of 32.57, 4.58, 4.16 and 4.73, respectively. After HepG2/ADM cells were treated with Fe3O4 for 48 h, drug-resistant cells sensitivity to 4 drugs was enhanced and IC50 decreased significantly, while reversal times of drug resistance were 3.65, 3.48, 2.67, and 2.58 times, respectively. Moreover, apoptosis rate of hepatoma group (52.31±4.28) was lower than that of multidrug resistance group (74.25±6.81) (P <0.05). The apoptosis rate of multidrug resistance group was higher than that of nano group (22.41±3.14) (P <0.05). Signal transducer and activator of transcription 3 (STAT3) and survivin gene and protein expressions in HCC group were less than multidrug resistance group (P <0.05). STAT3 and survivin gene and protein expressions in the multidrug resistance group were greater than nano group (P <0.05). In conclusion, Fe3O4 magnetic nanoparticles may facilitate reversal and apoptosis of liver cancer multidrug resistant cells by inhibiting the expression of survivin.

Publisher

American Scientific Publishers

Subject

General Materials Science

Reference47 articles.

1. Response evaluation criteria in cancer of the liver version 5 (RECICL 2019 revised version);Kudo;Hepatology Research,2019

2. Hepatocellular carcinoma: Management of an increasingly common problem;Davis;Proceedings (Baylor University Medical Center),2008

3. Tetrahedral framework nucleic acid-based delivery of resveratrol alleviates insulin resistance: From innate to adaptive immunity;Li;Nano-Micro Letters,2021

4. Redoxresponsive micelles integrating catalytic nanomedicine and selective chemotherapy for effective tumor treatment;Jin;Chinese Chemical Letters,2021

5. Drug discovery and drug marketing with the critical roles of modern administration;Chen;American Journal of Translational Research,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3